Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Terminated 4Withdrawn 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5Tumor-Agnostic 3Gastrointestinal 3Breast 2

Conditions

Non-small Cell Lung Cancer Metastatic 2Stomach Neoplasms 1Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) 1Non-squamous Non-small Cell Lung Cancer 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
tusamitamab ravtansine × Thoracic × Clear all
NCT04154956 2026-05-18

CARMEN-LC03

Sanofi

Phase 3 Terminated
389 enrolled 16 charts
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT04524689 2025-10-29

CARMEN-LC05

Sanofi

Phase 2 Terminated
57 enrolled 26 charts
Thoracic

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

NCT05245071 2025-08-29

CARMEN-LC06

Sanofi

Phase 2 Terminated
22 enrolled 11 charts
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT04394624 2025-06-06

CARMEN-LC04

Sanofi

Phase 2 Terminated
31 enrolled 22 charts
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT05703555 2024-02-28

INTRUSION

Erasmus Medical Center

Phase 2 Withdrawn
BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡